A detailed history of Org Partners LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Org Partners LLC holds 2,250 shares of IBRX stock, worth $5,512. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,250
Previous 1,150 95.65%
Holding current value
$5,512
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$2.24 - $3.01 $2,464 - $3,310
1,100 Added 95.65%
2,250 $5,000
Q2 2025

Jul 16, 2025

BUY
$1.89 - $3.44 $2,173 - $3,956
1,150 New
1,150 $3,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $981M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.